Viewing StudyNCT00035997



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00035997
Status: COMPLETED
Last Update Posted: 2009-11-23
First Post: 2002-05-07

Brief Title: Open-label Trial on the Effect of IV Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
Bone Metastasis View
Hormone-sensitive Prostate Cancer View
Prostate Cancer View